[1]
S. Bettuzzi, “The new anti-oncogene Clusterin and the molecular profiling of prostate cancer progression and prognosis”, Acta Biomed, vol. 74, no. 2, pp. 101–104, Aug. 2003, Accessed: Jul. 27, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/actabiomedica/article/view/2133